return to news
  1. SENSEX down 112 pts, NIFTY50 at 25,299 in noon deals; L&T, Hindustan Copper among buzzing stocks

Market News

SENSEX down 112 pts, NIFTY50 at 25,299 in noon deals; L&T, Hindustan Copper among buzzing stocks

Abha Raverkar

5 min read | Updated on January 29, 2026, 12:43 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

The stock of Gland Pharma gained as much as 9.32% to the session’s peak of ₹1,847.10 per equity share, as it reported its December quarter earnings post-market hours on Wednesday.

top gainers and losers, sensex, nifty50, market, buzzing stocks

On Wednesday, the foreign institutional investors (FIIs) bought stocks worth ₹480.26 crore on a net basis. | Image: Shutterstock

The Indian benchmark indices, SENSEX and NIFTY50, were trading in negative territory during the afternoon session on Thursday, January 29, amid losses in other Asian markets as the US Federal Reserve decided to keep policy rates unchanged.

Open FREE Demat Account within minutes!
Join now

The SENSEX plunged by as much as 636.74 points to an intraday low of 81,707.94. Meanwhile, the NIFTY50 touched the session’s low of 25,159.80.

At 12:31 PM, the S&P BSE SENSEX fell by 111.99 points, or 0.14%, to 82,232.69. NSE’s NIFTY50 was trading at 25,299.40, reflecting a 43.35 points, or 0.17% decline.

On Wednesday, the foreign institutional investors (FIIs) bought stocks worth ₹480.26 crore, while the domestic institutional investors (DIIs) purchased equities worth ₹3,360.59 crore on a net basis, according to exchange data.

The NIFTY50 index was weighed down by Asian Paints (-3.65%), Mahindra & Mahindra (-3.28%), SBI Life Insurance Company (-3.31%), InterGlobe Aviation (-2.93%) and Maruti Suzuki India (-2.63%), which were among the top losers.

On the other hand, the top gainers included Larsen & Toubro (3.51%), NTPC (2.64%), Hindalco Industries (2.40%), Oil & Natural Gas Corporation (2.22%) and Tata Steel (2.06%).

Buzzing stocks on January 29: Check list

L&T

Shares of Larsen & Toubro surged as much as 3.82% to an intraday high of ₹3,939 per unit on the National Stock Exchange (NSE) on Thursday, January 29, a day after reporting its results for Q3FY26.

The company reported a 4.2% YoY fall in consolidated profit after tax (PAT) at ₹3,215 crore for the December quarter of FY26 on the back of higher expenses. It had posted a PAT of ₹3,359 crore in the year-ago period.

The total consolidated PAT for the quarter at ₹3,215 crore includes a one-time material provision of ₹1,191 crore (net of tax & NCI) towards employee benefits arising from the implementation of the new labour codes, which has been classified under exceptional items.

However, its revenue from operations in the October-December period rose 10.49% annually to ₹71,450 crore from ₹64,668 crore logged in the year-ago period, the filing said.

For Q3 FY26, its EBITDA jumped 18.5% year-on-year (YoY) to ₹7,417 crore as against ₹6,255 crore in Q3 FY25. Its margin expanded at 10.38% in contrast to 9.67%.

Hindustan Copper

Hindustan Copper stock rallied as much as 17.61% to hit its 52-week high of ₹745 on the NSE on January 29, as copper futures (delivery in February) hit a lifetime high of ₹1,432.35 on the MCX today.

Copper also reached a record high in international markets, driven by strong investor demand for physical assets amid geopolitical tensions and a weaker dollar.

Maruti Suzuki India

Shares of Maruti Suzuki fell as much as 3.5% to an intraday low of ₹14,353 apiece, after it posted its earnings for the December quarter of FY26.

It reported a net profit of ₹3,794 crore in Q3FY26, marking an increase of nearly 4% from ₹3,659 crore in the same period last year.

Maruti Suzuki said that it incurred an exceptional expense of ₹594 crore on account of the implementation of four new labour codes.

Maruti Suzuki's total revenue from operations during the October-December period rose 29% annually to ₹49,891 crore as against ₹38,752 crore in the year-ago period.

Gland Pharma

The stock of Gland Pharma gained as much as 9.32% to the session’s peak of ₹1,847.10 per equity share, as it reported its December quarter earnings post-market hours on Wednesday.

The drug maker reported a net profit of ₹261 crore in the third quarter of FY26, reflecting an increase of 28% YoY from ₹205 crore in the same period last year.

Gland Pharma's revenue from operations jumped 23% annually to ₹1,695 crore in the October-December period from ₹1,384 crore in the year-ago period.

The company’s EBITDA advanced 21% YoY to ₹435 crore, but its EBITDA margin contracted by 40 basis points to 25.65%.

IndiGo

Shares of IndiGo’s parent company, InterGlobe Aviation, fell as much as 3.44% to an intraday low of ₹4,585.50 apiece on Thursday.

This is despite the company’s CEO, Pieter Elbers, being bullish on its international expansion. On Wednesday, Elbers stated that the airline aims to have nearly 40% overseas capacity and a total of over 4,000 daily flights, including domestic ones, by 2030.

Elbers said the airline aims to carry 200 million passengers and operate over 4,000 routes by 2030. In 2025, the carrier flew 124 million passengers.

SBI Life Insurance Company

SBI Life Insurance Company's stock declined as much as 3.72% to the day’s low of ₹1,976.90 per equity share, despite reporting a 5% increase in net profit at ₹577 crore for the third quarter ended December 2025.

The life insurance company promoted by SBI had earned a profit of ₹551 crore in the same quarter of the previous fiscal year.

During the quarter, net premium income improved to ₹30,245 crore as against ₹24,828 crore in the same quarter a year ago, SBI Life said in a regulatory filing.


Disclaimer: This article is purely for informational purposes and should not be considered investment advice from Upstox. Please consult with a financial advisor before making any investment decisions.
To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Abha Raverkar
Abha Raverkar is a post-graduate in economics from Christ University, Bengaluru. She has a strong interest in the markets and loves to unravel the nitty-gritties of the latest happenings in the world of markets, business, and the economy.

Next Story